Introduction to Refractory Recurrent
Sentence Examples
Discover more insights into Refractory Recurrent
Keywords frequently search together with Refractory Recurrent
Narrow sentence examples with built-in keyword filters
Refractory Recurrent sentence examples within squamous cell carcinoma
Anti-programmed cell death protein 1 (PD-1) agents have become the standard of care for platinum-refractory recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) and are currently being evaluated in various disease settings.
Full Text
ObjectivesIn the CheckMate 141 trial (NCT02105636), nivolumab demonstrated survival, health-related quality of life, and healthcare resource utilization benefits vs single-agent therapy of investigator’s choice (IC) (methotrexate, docetaxel or cetuximab) in patients with platinum-refractory recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN).
Full Text
Refractory Recurrent sentence examples within metastatic squamous cell
In the Phase‐III clinical trial, CheckMate 141, nivolumab significantly improved survival versus standard of care in patients with platinum‐refractory recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN).
Full Text
Refractory Recurrent sentence examples within neck squamous cell
Key Points Question Is nivolumab or pembrolizumab more cost-effective for treatment of US patients with platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma? Findings In this cost-effectiveness analysis that included 487 patients, when the willingness-to-pay threshold was $100 000 per quality-adjusted life-year, for patients weighing less than 72 kg, nivolumab (3 mg/kg administered biweekly) was considered cost-effective; otherwise, pembrolizumab was preferable.
Full Text
Learn more from Refractory Recurrent
Refractory Recurrent sentence examples within refractory recurrent clostridial
Background Fecal microbiota transplantation (FMT) is now approved for the treatment of refractory recurrent clostridial colitis, but a number of studies are ongoing in inflammatory bowel diseases, i.
Full Text
BackgroundFecal microbiota transplantation (FMT) has been recently approved by FDA for the treatment of refractory recurrent clostridial colitis (rCDI).
Full Text
Conclusions In platinum-sensitive recurrent ovarian cancer, PLD plus carbo was more effective than PAC plus carbo, while in platinum-resistant or -refractory recurrent ovarian cancer, PLD exhibited similar survival to other monotherapies.
Full Text
Here, we describe the outcome of the infusion of in vitro expanded CMV-reactive T-cells, taken from a healthy CMV-seropositive donor, in a liver-transplanted recipient with a refractory recurrent CMV.
Full Text
We report on a patient with chemotherapy-refractory recurrent VCCC, who was found to have high tumor programmed death-ligand 1 (PD-L1) combined positive score (CPS), and subsequently experienced a durable partial response (PR), after treatment with off-label fifth-line pembrolizumab.
Full Text
• VBT is a good clinical option for patients with refractory recurrent ISR in the DES era.
Full Text
We report a case of 72-year-old male, with chronic alcohol abuse, presenting with atypical features like refractory recurrent secondary generalized seizures and behavioral disturbances with increased irritability, initially mistreated as alcohol withdrawal.
Full Text
Current guidelines unfortunately reflect this inertia, as there is relative paucity of additional therapies for patients with refractory recurrent pericarditis Cardiovascular Imaging, Cleveland Clinic, Cleveland, Ohio, USA.
Full Text
OBJECTIVE
To evaluate the effectiveness of etanercept in the treatment of refractory recurrent spontaneous abortion with innate immune disorders.
Full Text
6073Background: Nivo, which inhibits the programmed death-1 (PD-1) receptor, improved survival for pts with platinum-refractory recurrent/metastatic HNSCC.
Full Text
Anti-programmed cell death 1 (PD-1) therapies, currently approved for platinum-refractory recurrent and/or metastatic HNSCC, offer the prospect of long-term remissions with fewer toxicities than traditional cytotoxic chemotherapy for a minority of patients, and are expected to advance to earlier lines of therapy.
Full Text
e17502Background: To evaluate the efficacy and safety of apatinib in treating patients with platinum-resistant or platinum-refractory recurrent or metastatic nasopharyngeal carcinoma.
Full Text
Background Fecal microbiota transplantation (FMT) is now approved for the treatment of refractory recurrent clostridial colitis, but a number of studies are ongoing in inflammatory bowel diseases, i.
Full Text
In this study we assessed the effectiveness, safety and feasibility of prophylactic treatment with intravesical gentamicin in patients with refractory recurrent urinary tract infections caused by multidrug resistant microorganisms.
Full Text
Background: Refractory recurrent ventricular tachycardia is a difficult therapeutic problem.
Full Text
Some subgroups of patients show refractory recurrent bleeding despite standard endoscopic therapy.
Full Text
Nearly 10 years after the approval of cetuximab, anti-PD1/PD-L1 checkpoint inhibitors are the first drugs that have shown any survival benefit for the treatment on platinum-refractory recurrent/metastatic (R/M) HNSCC.
Full Text
Objective
To investigate the efficacy of thalidomide combined with DICE scheme in the treatment of refractory recurrent non-hodgkin lymphoma patients and the occurrence of toxic and side effects.
Full Text
BackgroundFecal microbiota transplantation (FMT) has been recently approved by FDA for the treatment of refractory recurrent clostridial colitis (rCDI).
Full Text
A patient with platinum-refractory recurrent oral cavity HNSCC underwent comprehensive genomic profiling (CGP) that identified an activating MET mutation (R1004).
Full Text
We report a successful first birth case from a patient with refractory recurrent implantation failure (RIF) by using endometrial receptivity array (ERA) test in Japan.
Full Text
Long half-life SST analogues are now recommended for the systemic treatment of unresectable or radiation-refractory recurrent human meningiomas.
Full Text
Background To evaluate the efficacy and safety of apatinib in treating patients with platinum-resistant or platinum-refractory recurrent or metastatic nasopharyngeal carcinoma.
Full Text
The prognosis of refractory recurrent RMS is extremely poor, and the 5-year survival rate is less than 20%.
Full Text